TORONTO (Reuters) - Canadian homicide detectives on Sunday took the lead in investigating the mysterious deaths of pharmaceuticals billionaire Barry Sherman and his wife, Honey, a day after relatives complained about the handling of the case.
The development does not mean the deaths are being treated as homicides, Toronto Police Service spokeswoman Michelle Flannery told Reuters.
The couple, who were celebrated for their philanthropy and financial success, were found on Friday hanging from a railing by the side of their pool by a real estate agent involved with selling their house in Toronto, Canadian media reported.
Police have said there was no sign of forced entry to the home, which is listed for sale at C$6.9 million ($5.4 million).
Autopsies conducted on Saturday and Sunday determined that Barry Sherman, 75, and his wife, 70, died from ligature neck compression, police said in a statement. They asked anybody with information on the case to contact authorities.
Flannery would not say whether police were looking for a suspect. Police had said on Saturday they had nobody in custody and were not seeking any suspects.
The case has dominated the Canadian news, with employees, friends and leading politicians expressing shock.
The Globe and Mail, Toronto Sun and Toronto Star reported Saturday that police were operating on the theory that Barry Sherman had killed his wife and hanged himself.
A statement issued late Saturday on behalf of the Shermans’ four children criticized that idea.
“We are shocked and think it’s irresponsible that police sources have reportedly advised the media of a theory which neither their family, their friends nor their colleagues believe to be true,” the statement reads.
“We urge the Toronto Police Service to conduct a thorough, intensive and objective criminal investigation,” it said.
Barry Sherman founded Apotex Inc in 1974 and built it into one of the world’s biggest generic drug makers, making him one of Canada’s richest people.
Reporting by Anna Mehler Paperny in Toronto; Editing by Jim Finkle, Peter Cooney and Paul Simao
Our Standards: The Thomson Reuters Trust Principles.